Adverse events that were more frequent (>5%) in patients treated with ELIDEL Cream compared to vehicle were headache (14% vs. 9%) in the short-term trial.
Nasopharyngitis (26% vs. 21%), influenza (13% vs. 4%), pharyngitis (8% vs. 3%), viral infection (7% vs. 1%), pyrexia (13% vs. 5%), cough (16% vs. 11%), and headache (25% vs. 16%) were increased over vehicle in the 1-year safety study (see ADVERSE REACTIONS).
Other side effects include headache, common cold or stuffy nose, sore throat, influenza, fever, viral infection, and cough.
Section
Not stated
Context
More frequent than vehicle in the short-term trial and increased over vehicle in the 1-year safety study.